This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fitoussi, F.
Right arrow Articles by Bingen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fitoussi, F.
Right arrow Articles by Bingen, E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2001, p. 1889-1891, Vol. 45, No. 6
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.6.1889-1891.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France

Frederic Fitoussi,1 Chawki Loukil,1 Isabelle Gros,2 Olivier Clermont,1 Patricia Mariani,1 Stephane Bonacorsi,1 Isabelle Le Thomas,1 Dominique Deforche,1 and Edouard Bingen1,*

Service de Microbiologie, Hôpital Robert Debré, 75019 Paris,1 and Service de Microbiologie Hôpital Delafontaine, 93200 Saint Denis,2 France

Received 12 January 2001/Returned for modification 19 February 2001/Accepted 17 March 2001

Macrolide susceptibility was investigated in clinical group B streptococci obtained from neonates or pregnant women in 2000 in France. Of 490 consecutive isolates, 18% were resistant to erythromycin. The erm(B), erm(A) subclass erm(TR), and mef(A) genes were harbored by 47, 45, and 6% of these strains, respectively. Two isolates did not harbor erm or mef genes.

* Corresponding author. Mailing address: Service de Microbiologie, Hôpital R. Debré, 48 Bd Sérurier, 75019 Paris, France. Phone: 33 (1) 40 03 23 40. Fax: 33 (1) 40 03 24 50. E-mail: edouard.bingen{at}rdb.ap-hop-paris.fr.

Antimicrobial Agents and Chemotherapy, June 2001, p. 1889-1891, Vol. 45, No. 6
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.6.1889-1891.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Tazi, A., Reglier-Poupet, H., Raymond, J., Adam, J.-M., Trieu-Cuot, P., Poyart, C. (2007). Comparative evaluation of VITEK 2(R) for antimicrobial susceptibility testing of group B Streptococcus. J Antimicrob Chemother 59: 1109-1113 [Abstract] [Full Text]  
  • Amezaga, M. R., McKenzie, H. (2006). Molecular epidemiology of macrolide resistance in {beta}-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). J Antimicrob Chemother 57: 443-449 [Abstract] [Full Text]  
  • Zeng, X., Kong, F., Wang, H., Darbar, A., Gilbert, G. L. (2006). Simultaneous Detection of Nine Antibiotic Resistance-Related Genes in Streptococcus agalactiae Using Multiplex PCR and Reverse Line Blot Hybridization Assay. Antimicrob. Agents Chemother. 50: 204-209 [Abstract] [Full Text]  
  • Marimon, J. M., Valiente, A., Ercibengoa, M., Garcia-Arenzana, J. M., Perez-Trallero, E. (2005). Erythromycin Resistance and Genetic Elements Carrying Macrolide Efflux Genes in Streptococcus agalactiae. Antimicrob. Agents Chemother. 49: 5069-5074 [Abstract] [Full Text]  
  • Culebras, E., Rodriguez-Avial, I., Betriu, C., Picazo, J. J. (2005). Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae. J Antimicrob Chemother 56: 836-840 [Abstract] [Full Text]  
  • Fluegge, K., Supper, S., Siedler, A., Berner, R. (2004). Antibiotic Susceptibility in Neonatal Invasive Isolates of Streptococcus agalactiae in a 2-Year Nationwide Surveillance Study in Germany. Antimicrob. Agents Chemother. 48: 4444-4446 [Abstract] [Full Text]  
  • Uh, Y., Jang, I. H., Hwang, G. Y., Lee, M. K., Yoon, K. J., Kim, H. Y. (2004). Serotypes and Genotypes of Erythromycin-Resistant Group B Streptococci in Korea. J. Clin. Microbiol. 42: 3306-3308 [Abstract] [Full Text]  
  • Acikgoz, Z. C., Almayanlar, E., Gamberzade, S., Gocer, S. (2004). Macrolide Resistance Determinants of Invasive and Noninvasive Group B Streptococci in a Turkish Hospital. Antimicrob. Agents Chemother. 48: 1410-1412 [Abstract] [Full Text]  
  • Bingen, E., Doit, C., Bidet, P., Brahimi, N., Deforche, D. (2004). Telithromycin Susceptibility and Genomic Diversity of Macrolide-Resistant Serotype III Group B Streptococci Isolated in Perinatal Infections. Antimicrob. Agents Chemother. 48: 677-680 [Abstract] [Full Text]  
  • Lopardo, H. A., Vidal, P., Jeric, P., Centron, D., Paganini, H., Facklam, R. R., Elliott, J. (2003). Six-Month Multicenter Study on Invasive Infections Due to Group B Streptococci in Argentina. J. Clin. Microbiol. 41: 4688-4694 [Abstract] [Full Text]  
  • Diekema, D. J., Andrews, J. I., Huynh, H., Rhomberg, P. R., Doktor, S. R., Beyer, J., Shortridge, V. D., Flamm, R. K., Jones, R. N., Pfaller, M. A. (2003). Molecular Epidemiology of Macrolide Resistance in Neonatal Bloodstream Isolates of Group B Streptococci. J. Clin. Microbiol. 41: 2659-2661 [Abstract] [Full Text]  
  • Culebras, E., Rodriguez-Avial, I., Betriu, C., Redondo, M., Picazo, J. J. (2002). Macrolide and Tetracycline Resistance and Molecular Relationships of Clinical Strains of Streptococcus agalactiae. Antimicrob. Agents Chemother. 46: 1574-1576 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»